A critical discovery in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently disabled in various types of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research